Literature DB >> 26412087

Genetic architecture of renal cell carcinoma: Do we have to know?

Hakan Öztürk1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26412087     DOI： 10.1007/s00345-015-1697-y

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  16 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.

Authors:  Manish A Vira; Kristian R Novakovic; Peter A Pinto; W Marston Linehan
Journal:  BJU Int       Date:  2007-05       Impact factor: 5.588

3.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

Authors:  Jennifer S Isaacs; Yun Jin Jung; David R Mole; Sunmin Lee; Carlos Torres-Cabala; Yuen-Li Chung; Maria Merino; Jane Trepel; Berton Zbar; Jorge Toro; Peter J Ratcliffe; W Marston Linehan; Len Neckers
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

4.  Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.

Authors:  R F Schwerdtle; S Störkel; C Neuhaus; H Brauch; E Weidt; W Brenner; R Hohenfellner; C Huber; H J Decker
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

Review 5.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

6.  UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.

Authors:  Youfeng Yang; Vladimir A Valera; Hesed M Padilla-Nash; Carole Sourbier; Cathy D Vocke; Manish A Vira; Mones S Abu-Asab; Gennady Bratslavsky; Maria Tsokos; Maria J Merino; Peter A Pinto; Ramaprasad Srinivasan; Thomas Ried; Len Neckers; W Marston Linehan
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

Review 7.  The genetic basis of cancer of the kidney.

Authors:  W Marston Linehan; McClellan M Walther; Berton Zbar
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

8.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

9.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.

Authors:  Ignacio Varela; Patrick Tarpey; Keiran Raine; Dachuan Huang; Choon Kiat Ong; Philip Stephens; Helen Davies; David Jones; Meng-Lay Lin; Jon Teague; Graham Bignell; Adam Butler; Juok Cho; Gillian L Dalgliesh; Danushka Galappaththige; Chris Greenman; Claire Hardy; Mingming Jia; Calli Latimer; King Wai Lau; John Marshall; Stuart McLaren; Andrew Menzies; Laura Mudie; Lucy Stebbings; David A Largaespada; L F A Wessels; Stephane Richard; Richard J Kahnoski; John Anema; David A Tuveson; Pedro A Perez-Mancera; Ville Mustonen; Andrej Fischer; David J Adams; Alistair Rust; Waraporn Chan-on; Chutima Subimerb; Karl Dykema; Kyle Furge; Peter J Campbell; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2011-01-19       Impact factor: 49.962

10.  Identification of genes and pathways involved in kidney renal clear cell carcinoma.

Authors:  William Yang; Kenji Yoshigoe; Xiang Qin; Jun S Liu; Jack Y Yang; Andrzej Niemierko; Youping Deng; Yunlong Liu; A Dunker; Zhongxue Chen; Liangjiang Wang; Dong Xu; Hamid R Arabnia; Weida Tong; Mary Yang
Journal:  BMC Bioinformatics       Date:  2014-12-16       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.